ELND005 in Patients With Mild to Moderate Alzheimer's Disease

NCT00568776 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Placebo Control
DRUG: ELND005
DRUG: ELND005
DRUG: ELND005

Sponsor

OPKO Health, Inc.